950 — Lee's Pharmaceutical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$694.83m
- HK$649.61m
- HK$1.05bn
- 59
- 58
- 39
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 123 | 134 | 1,969 | 67.9 | 30.8 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 135 | 107 | -1,902 | 71.6 | 28.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 47.7 | -149 | -3.45 | -8.36 | -98.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 400 | 219 | 211 | 284 | 110 |
Capital Expenditures | -361 | -358 | -371 | -214 | -160 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 99.2 | -166 | 0.443 | -42.2 | 14.5 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -261 | -524 | -370 | -256 | -145 |
Financing Cash Flow Items | 400 | 31.2 | 0 | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 324 | -9.8 | 61 | -129 | 13.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 471 | -318 | -97.7 | -88.2 | -21.8 |